BRCA1 and breast cancer: Additionally, BRCA1-mutated breast cancer also shares phenotypic similarities such as morphology, molecular subtype, and responsiveness to poly-(adenosine diphosphate-ribose) polymerase inhibitors (PARPi) treatment.